Oppenheimer has increased its price target for Microsoft stock to $570 from $515, maintaining an 'Outperform' rating due to accelerating growth in Azure, Microsoft 365, and AI businesses. The new target suggests a 13.6% upside from the current price of $501.61. The firm highlights strong adoption of Microsoft 365 Copilot and expanding AI infrastructure as key growth drivers, with expectations for sustained acceleration through fiscal 2027. Despite some risks like potential cloud margin pressure, analyst sentiment remains bullish, supported by robust AI and cloud revenue growth.
As of Sep 22, 2026 21:52 WIB, Microsoft shares on Pluang are priced at USD 497.85, showing a 0.75% decline in the past day. Despite the analyst's raised price target to $570, the stock currently trades slightly below the article's cited price of $501.61. Pluang data also shows a market cap of $3.72 trillion and a dividend yield of 0.78%, with a majority of 68% buy orders indicating continued investor interest.
In July, President Donald Trump disclosed 1,156 securities transactions totaling between $79 million and $270 million. The largest trades included sales of Microsoft and Amazon shares worth between $5 million and $25 million each on July 20. This act...
Steve Eisman, known for predicting the subprime crisis, warned that 70% of AI revenue among major cloud providers comes from just two companies, OpenAI and Anthropic, with OpenAI potentially facing trouble. This concentration risk raises concerns abo...
IREN has secured over 5 gigawatts of power capacity with major contracts totaling $13.1 billion from Microsoft and NVIDIA, positioning it as a key player in AI infrastructure. Despite this, the company reported a $684 million net loss in Q4 with reve...
Chinese President Xi Jinping is set to visit the U.S. from Wednesday to Friday, with several top American tech executives like Microsoft CEO Satya Nadella, Nvidia's Jensen Huang, and Apple's Tim Cook attending a key dinner in Washington, D.C. The Chi...
Microsoft's stock, up nearly 35% in six months but still below its all-time high, is forecasted by multiple Wall Street analysts to rally further. Patrick Walravens of Citizens maintains a 'Buy' rating with a 12-month price target of $550, citing CEO...
